Martindale: The Complete Drugs Reference

DESCRIPTION

– Breadth: No other source of drug information contains the wide range of content or the same level of detail, making it the ideal first-line reference work as well as a trusted source of information for detailed and complex drug enquiries

– Global coverage: The leading resource in terms of international content, including information from over 43 countries

– Objectivity: Respected for the accuracy of content, appraised and authored by experts with editorial independence from the pharmaceutical industry. Based on information from published papers, regulatory sources and guidelines, with extensive referencing

– International adoption: Recognised, trusted and adopted worldwide Martindale is depended upon by healthcare professionals throughout the world for its reliable and comprehensive information on international drugs and medicines. It is widely recognised for its unbiased and authoritative nature, as well as its unprecedented international coverage, including information from 43 countries and regions.

A team of experts use the most clinically relevant and reliable information, giving healthcare professionals a complete resource for reference on drugs and medicines.

Martindale contains proprietary drug information on preparations available worldwide, and remains a critical tool for identification of the local equivalent of a prescribed preparation and for assessing what alternatives might be suitable when needed.

Martindale: The Complete Drug Reference provides unbiased and evaluated information on drugs and medicines in use around the world. It is prepared by an experienced team of pharmacists and life scientists who use their professional expertise to select the most clinically relevant and appropriate information from reliable published sources, to provide an unbiased and evaluated digest of the literature.

Includes:

Over 6,300 drug monographs
Over 185,000 preparations
Over 54,000 reference citations
Over 20,000 manufacturers and distributors
Proprietary preparations from 43 countries and regions
Nearly 700 treatment reviews, with references from the published literature
Enables identification of medicines, the local equivalent and the manufacturer
Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines

Changes to this new edition:

More than 130 new monographs including:

Lumacaftor: a cystic fibrosis transmembrane conductance regulator (CFTR) protein corrector

Pitolisant: a central stimulant used in the treatment of narcolepsy

Rolapitant: a neurokinin-1 receptor antagonist that is used for the prevention of nausea and vomiting associated with cancer chemotherapy

Umeclidinium Bromide: a quaternary ammonium antimuscarinic used as a bronchodilator in the treatment of reversible airways obstruction

New Hepatitis C treatment table and drugs including ledipasvir, ombitasvir, paritaprevir, and dasabuvir

Coverage of proprietary preparations in 43 countries including Australia, China, UK, and USA, revised and updated